PT  - JOURNAL ARTICLE
AU  - Livio Fenga
TI  - Forecasting the CoViD–19 Diffusion in Italy and the Related Occupancy of Intensive Care Units
AID  - 10.1101/2020.03.30.20047894
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.30.20047894
4099  - http://medrxiv.org/content/early/2020/04/01/2020.03.30.20047894.short
4100  - http://medrxiv.org/content/early/2020/04/01/2020.03.30.20047894.full
AB  - This paper provides a model–based method for the forecast of the total number of currently CoVoD-19 positive individuals and of the occupancy of the available Intensive Care Units in Italy. The predictions obtained – for a time horizon of 10 days starting from March 29th – will be provided at a national as well as at a more disaggregate levels, following a criterion based on the magnitude of the phenomenon. While the Regions which have been hit the most by the pandemic have been kept separated, the less affected ones have been aggregated into homogeneous macro-areas. Results show that – within the forecast period considered (March 29th - April 7th) – all of the Italian regions will show a decreasing number of CoViD-19 positive people. Same for the number of people who will need to be hospitalized in a Intensive Care Unit (ICU). These estimates are valid under constancy of the Government’s current containment policies. In this scenario, Northern Regions will remain the most affected ones and no significant outbreak are foreseen in the southern regions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe submitted paper has not been supported in any way.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used in my paper can be freely accessed on the internet https://www.iss.it/